New Peptide-Based Pharmacophore Activates 20S Proteasome
The proteasome is a pivotal element of controlled proteolysis, responsible for the catabolic arm of proteostasis. By inducing apoptosis, small molecule inhibitors of proteasome peptidolytic activities are successfully utilized in treatment of blood cancers. However, the clinical potential of proteas...
Main Authors: | Paweł A. Osmulski, Przemysław Karpowicz, Elżbieta Jankowska, Jonathan Bohmann, Andrew M. Pickering, Maria Gaczyńska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/6/1439 |
Similar Items
-
The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
by: Nathalie Vigneron, et al.
Published: (2015-09-01) -
A widespread family of serine/threonine protein phosphatases shares a common regulatory switch with proteasomal proteases
by: Niels Bradshaw, et al.
Published: (2017-05-01) -
The proteasome and the degradation of oxidized proteins: Part I—structure of proteasomes
by: Tobias Jung, et al.
Published: (2013-01-01) -
Synthesis and SAR Study of Novel Peptide Aldehydes as Inhibitors of 20S Proteasome
by: Lihe Zhang, et al.
Published: (2011-09-01) -
Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing
by: Wayne Paes, et al.
Published: (2020-09-01)